The FDA is collaborating with real-world data partner, Aetion, to conduct research on the spread of COVID-19. The project aims to gather information on diagnostic and treatment patterns to better understand the natural course of the virus. It will also identify risk factors for complications, follow medication use, and contribute to evaluations of potential interventions.
Read More
Read More